{
    "2019-02-08": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Q4 Earnings",
                        "Report"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "Incyte Down as FDA Extends Review Period of Jakafi for GVHD",
                "features": {
                    "keywords": [
                        "Incyte",
                        "FDA",
                        "Jakafi",
                        "GVHD",
                        "Review Period"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-28",
                "original_text": "Ligand (LGND) Beats on Q4 Earnings & Sales, Raises '19 View",
                "features": {
                    "keywords": [
                        "Ligand",
                        "Q4 Earnings",
                        "Sales",
                        "Raises View"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-07",
                "original_text": "Ligand Pharmaceuticals Inc (LGND) Q4 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Ligand Pharmaceuticals",
                        "Q4 2018",
                        "Earnings",
                        "Conference Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}